Terms: = Bone cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Prognosis
39 results:
1. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
Yun HM; Kwon HS; Lee JY; Park KR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
[TBL] [Abstract] [Full Text] [Related]
2. Combined SET7/9 and cdk4 inhibition act synergistically against osteosarcoma.
Shi Y; Wang Z; Shao Y; Guang Q; Zhang J; Liu B; Wu C; Wang Y; Sui P
Biochem Biophys Res Commun; 2024 May; 708():149808. PubMed ID: 38520914
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
4. Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast cancer: A Retrospective Analysis of the MONARCH 2 Trial.
Gerratana L; Kocherginsky M; Davis AA; D'Amico P; Reduzzi C; Puglisi F; Cristofanilli M
Oncologist; 2024 Feb; 29(2):123-131. PubMed ID: 37935631
[TBL] [Abstract] [Full Text] [Related]
5. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
6. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
Tefferi A; Alkhateeb H; Gangat N
Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
[TBL] [Abstract] [Full Text] [Related]
7. First diagnosed invasive lobular carcinoma of the breast combined with gastric metastasis and bone metastasis: a case report and review of the literature.
Sun L; Liu J; Guo M; Xu J; Wang D
BMC Womens Health; 2023 Mar; 23(1):133. PubMed ID: 36966290
[TBL] [Abstract] [Full Text] [Related]
8. Generation and characterization of patient-derived xenografts from patients with osteosarcoma.
Chen F; Zhang Z; Shen R; Chen M; Li G; Zhu X
Tissue Cell; 2022 Dec; 79():101911. PubMed ID: 36156374
[TBL] [Abstract] [Full Text] [Related]
9. Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
Zhang Y; Xu W; Wang Y; Li J; He G; Guan M; Zeng X; Bian W; Song Y; Liu J
Bioengineered; 2022 Mar; 13(3):5962-5974. PubMed ID: 35184675
[TBL] [Abstract] [Full Text] [Related]
10. Peritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast cancer: A Case Report and Review of the Literature.
Gao HF; Zhang JS; Zhang QZ; Zhu T; Yang CQ; Zhang LL; Yang M; Ji F; Li JQ; Cheng MY; Niu G; Wang K
Front Endocrinol (Lausanne); 2021; 12():659537. PubMed ID: 34690920
[TBL] [Abstract] [Full Text] [Related]
11. Abemaciclib is synergistic with doxorubicin in osteosarcoma pre-clinical models via inhibition of cdk4/6-Cyclin D-Rb pathway.
Wang D; Bao H
Cancer Chemother Pharmacol; 2022 Jan; 89(1):31-40. PubMed ID: 34655298
[TBL] [Abstract] [Full Text] [Related]
12. Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Porazzi P; De Dominici M; Salvino J; Calabretta B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573335
[TBL] [Abstract] [Full Text] [Related]
13. Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell Death.
Spirin P; Shyrokova E; Lebedev T; Vagapova E; Smirnova P; Kantemirov A; Dyshlovoy SA; Amsberg GV; Zhidkov M; Prassolov V
Mar Drugs; 2021 Aug; 19(9):. PubMed ID: 34564151
[TBL] [Abstract] [Full Text] [Related]
14. CDK6 Is a Therapeutic Target in Myelofibrosis.
Dutta A; Nath D; Yang Y; Le BT; Mohi G
Cancer Res; 2021 Aug; 81(16):4332-4345. PubMed ID: 34145036
[TBL] [Abstract] [Full Text] [Related]
15. Low-grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw.
Sasaki A; Miyashita H; Kawaida M; Kameyama K
Clin Exp Dent Res; 2021 Dec; 7(6):1175-1182. PubMed ID: 34008925
[TBL] [Abstract] [Full Text] [Related]
16. Accelerated Phase of Myeloproliferative Neoplasms.
Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
[TBL] [Abstract] [Full Text] [Related]
17. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies.
Yang CF; Gau JP; Hsiao LT; Hsu CY
Pathology; 2021 Oct; 53(6):740-745. PubMed ID: 33745704
[TBL] [Abstract] [Full Text] [Related]
18. Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.
Gerratana L; Davis AA; Polano M; Zhang Q; Shah AN; Lin C; Basile D; Toffoli G; Wehbe F; Puglisi F; Behdad A; Platanias LC; Gradishar WJ; Cristofanilli M
Eur J Cancer; 2021 Jan; 143():147-157. PubMed ID: 33307492
[TBL] [Abstract] [Full Text] [Related]
19. Initial experience with cdk4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany.
Schneeweiss A; Ettl J; Lüftner D; Beckmann MW; Belleville E; Fasching PA; Fehm TN; Geberth M; Häberle L; Hadji P; Hartkopf AD; Hielscher C; Huober J; Ruckhäberle E; Janni W; Kolberg HC; Kurbacher CM; Klein E; Lux MP; Müller V; Nabieva N; Overkamp F; Tesch H; Laakmann E; Taran FA; Seitz J; Thomssen C; Untch M; Wimberger P; Wuerstlein R; Volz B; Wallwiener D; Wallwiener M; Brucker SY
Breast; 2020 Dec; 54():88-95. PubMed ID: 32956934
[TBL] [Abstract] [Full Text] [Related]
20. Stromal osseous metaplasia in urothelial carcinoma of the bladder: a rare case report and literature review.
Razafimahefa J; Gosset C; Mongiat-Artus P; Andriamampionona TF; Verine J
Diagn Pathol; 2019 Jul; 14(1):75. PubMed ID: 31299983
[TBL] [Abstract] [Full Text] [Related]
[Next]
